Výsledky vyhledávání - "Georgina Paz De la Rosa"

Akademický článek

Interim safety and immunogenicity results from an NDV-based COVID-19 vaccine phase I trial in Mexico

Publikováno v: npj Vaccines, Vol 8, Iss 1, Pp 1-14 (2023)

Abstract There is still a need for safe, efficient, and low-cost coronavirus disease 2019 (COVID-19) vaccines that can stop transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Here we evaluated a vaccine candidate based on a

Externí odkaz: https://doaj.org/article/d2ac0c69327549fb9217708e2039498c

Zobrazit plný text záznamu

Akademický článek

Newcastle disease virus vector-based SARS-CoV-2 vaccine candidate AVX/COVID-12 activates T cells and is recognized by antibodies from COVID-19 patients and vaccinated individuals

Publikováno v: Frontiers in Immunology, Vol 15 (2024)

IntroductionSeveral effective vaccines for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) have been developed and implemented in the population. However, the current production capacity falls short of meeting global demand. Therefore, i

Externí odkaz: https://doaj.org/article/f59adc9f44cc4bf6920104dbbb786afe

Zobrazit plný text záznamu

Akademický článek

Safety and Immunogenicity of a Newcastle Disease Virus Vector-Based SARS-CoV-2 Vaccine Candidate, AVX/COVID-12-HEXAPRO (Patria), in Pigs

Autor: Jesús Horacio Lara-Puente, Juan Manuel Carreño, Weina Sun, Alejandro Suárez-Martínez, Luis Ramírez-Martínez, Francisco Quezada-Monroy, Georgina Paz-De la Rosa, Rosalía Vigueras-Moreno, Gagandeep Singh, Oscar Rojas-Martínez, Héctor Elías Chagoya-Cortés, David Sarfati-Mizrahi, Ernesto Soto-Priante, Constantino López-Macías, Florian Krammer, Felipa Castro-Peralta, Peter Palese, Adolfo García-Sastre, Bernardo Lozano-Dubernard

Publikováno v: mBio, Vol 12, Iss 5 (2021)

Several highly efficacious vaccines for SARS-CoV-2 have been developed and are used in the population. However, the current production capacity cannot meet the global demand. Therefore, additional vaccines—especially ones that can be produced local

Externí odkaz: https://doaj.org/article/d47ce303ae344529b5dda46a5d3fc757

Zobrazit plný text záznamu

Safety and immunogenicity of a live recombinant Newcastle disease virus-based COVID-19 vaccine (Patria) administered via the intramuscular or intranasal route: Interim results of a non-randomized open label phase I trial in Mexico

Publikováno v: medRxiv

There is still a need for safe, efficient and low-cost coronavirus disease 2019 (COVID-19) vaccines that can stop transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Here we evaluated a vaccine candidate based on a live reco

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3bde479e654e6ef0648aed025d62266a
https://pubmed.ncbi.nlm.nih.gov/35169806

Zobrazit plný text záznamu

Safety and Immunogenicity of a Newcastle Disease Virus Vector-Based SARS-CoV-2 Vaccine Candidate, AVX/COVID-12-HEXAPRO (Patria), in Pigs

Autor: David Sarfati-Mizrahi, Bernardo Lozano-Dubernard, Héctor Elías Chagoya-Cortés, Rosalía Vigueras-Moreno, Peter Palese, Florian Krammer, Constantino López-Macías, Oscar Rojas-Martínez, Francisco Quezada-Monroy, Felipa Castro-Peralta, Juan Manuel Carreño, Ernesto Soto-Priante, Adolfo García-Sastre, Weina Sun, Alejandro Suárez-Martínez, Gagandeep Singh, Luis Ramírez-Martínez, Georgina Paz-De la Rosa, Jesus Horacio Lara-Puente

Publikováno v: mBio, Vol 12, Iss 5 (2021)
mBio

Vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) were developed in record time and show excellent efficacy and effectiveness against coronavirus disease 2019 (COVID-19). However, currently approved vaccines cannot meet th

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dc345961fcf6785368dd7a1928cfd35e
https://journals.asm.org/doi/10.1128/mBio.01908-21

Zobrazit plný text záznamu

A novel HPV 16 L1-based chimeric virus-like particle containing E6 and E7 seroreactive epitopes permits highly specific detection of antibodies in patients with CIN 1 and HPV-16 infection

Autor: Alberto Monroy-García, Yessica S Tapia-Guerrero, Mariel E Toledo-Guzmán, Miguel A. Gómez-Lim, Karyna Pérez-Saldaña, Edelmiro Santiago-Osorio, Georgina Paz de la Rosa, Benny Weiss-Steider, Héctor I Sanchez-Peña, María de Lourdes Mora-García, Jorge Hernández-Montes

Publikováno v: Virology Journal, Vol 8, Iss 1, p 59 (2011)
Virology Journal

Background The presence of IgG antibodies to HPV-16 L1-virus like particles (VLPs) in serum has been reported as a result of persistent exposure to the virus and as a marker of disease progression. However, detection of VLP-specific antibodies in ser

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::77313eca6b79eaf492734564ea0bea1d
http://www.virologyj.com/content/8/1/59

Zobrazit plný text záznamu

An HPV 16 L1-based chimeric human papilloma virus-like particles containing a string of epitopes produced in plants is able to elicit humoral and cytotoxic T-cell activity in mice

Autor: Miguel Angel Gómez Lim, Jorge Hernández-Montes, Georgina Paz de la Rosa, María de Lourdes Mora-García, Cristina Gehibie Reynaga Peña, Alberto Monroy-García, Benny Weiss-Steider

Publikováno v: Virology Journal, Vol 6, Iss 1, p 2 (2009)
Virology Journal

BackgroundEven though two prophylactic vaccines against HPV are currently licensed, infections by the virus continue to be a major health problem mainly in developing countries. The cost of the vaccines limits wide-scale application in poor countries

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::41a197df3bd0d483edbb50707339a8db
http://www.virologyj.com/content/6/1/2

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání